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Reactive oxygen species (ROS) scavengers have been shown to relieve persistent pain; however, the mechanism is not clearly understood.
Superoxide produced from mitochondrial oxidative phosphorylation is considered the major source of ROS in neurons during excitation
where mitochondrial superoxide levels are normally controlled by superoxide dismutase (SOD-2). The present study hypothesizes that
capsaicin-induced secondary hyperalgesia is a consequence of superoxide build-up in spinal dorsal horn neurons and SOD-2 is a major
determinant. To test this hypothesis, the spinal levels of SOD-2 activity, inactivated SOD-2 proteins, and mitochondrial superoxide were
measured and correlated to the levels of capsaicin-induced secondary hyperalgesia in mice with and without SOD-2 manipulations. The
data suggest that superoxide accumulation is a culprit in the abnormal sensory processing in the spinal cord in capsaicin-induced
secondary hyperalgesia. Our studies also support the notion that SOD-2 nitration is a critical mechanism that maintains elevated
superoxide levels in the spinal cord after capsaicin treatment. Finally, our findings suggest a therapeutic potential for the manipulation
of spinal SOD-2 activity in pain conditions.
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Introduction
Reactive oxygen species (ROS) are highly reactive oxygen con-
taining molecules that exert a cytotoxic effect in neurodegenera-
tive diseases, stroke, and the normal aging process (Jenner, 1994).
Cellular ROS levels are under the tight control of antioxidant
systems. The first and most crucial antioxidant is mitochondrial
superoxide dismutase (MnSOD; SOD-2), which neutralizes su-
peroxide by converting it into hydrogen peroxide (H2O2). Hy-
drogen peroxides are normally further metabolized into molec-
ular oxygen and water by either catalase or glutathione
peroxidase (Fridovich, 1995). Superoxide (O2
●) generated from
mitochondrial oxidative phosphorylation is a major source of
neuronal ROS (Jenner, 1994; Fridovich, 1995). Superoxide has
not received much consideration in persistent pain, but increased
ROS production is observed in injured peripheral nerve and in-
flamed tissue (Khalil et al., 1999; Levy et al., 1999; Cízková et al.,
2002; Twining et al., 2004; Park et al., 2006), and antioxidants
produce analgesia in both neuropathic (Tal, 1996; Khalil and
Khodr, 2001; Kim et al., 2004) and inflammation (Haley et al.,
1992; Wang et al., 1996; Coderre et al., 2004; Lee et al., 2007) pain.
However, the underlying mechanism by which ROS reduction
alleviates pain is not well understood.
The first step of establishing a clear understanding of ROS
mechanism in persistent pain is an identification of the major
action site: peripheral tissue, the spinal cord, etc. In the capsaicin-
induced pain model, an intradermal injection of capsaicin pro-
duces two distinctive pain components: primary and secondary
hyperalgesia. The primary hyperalgesia is caused by peripheral
sensitization and the secondary hyperalgesia is caused by central
sensitization (Willis, 2001). Therefore, the capsaicin-induced
pain model is an excellent model with which to identify the ROS
action site. In our earlier study in the rat, a significant analgesic
effect of ROS scavengers was observed in capsaicin-induced sec-
ondary hyperalgesia (Lee et al., 2007), suggesting ROS involve-
ment in the spinal cord. Furthermore, ROS accumulation was
observed primarily in the mitochondria of dorsal horn neurons
after capsaicin treatment in mice (Schwartz et al., 2008). These
results suggest that elevated mitochondrial ROS may be an im-
portant mechanism of capsaicin-induced hyperalgesia. Thus, we
hypothesize that the mitochondrial antioxidant SOD-2 is a criti-
cal determinant for mitochondrial superoxide accumulation and
subsequent capsaicin-induced secondary hyperalgesia. The im-
portance of SOD-2 has been suggested in a chronic inflammatory
pain model (Wang et al., 2004) and a NMDA-induced hyperal-
gesia (Muscoli et al. 2004). To test this hypothesis, the spinal
levels of SOD-2 protein, SOD-2 activity, and inactivated SOD-2
protein were measured in mice after a capsaicin injection to a
hind foot with and without ROS scavenger treatments.
Capsaicin-induced secondary hyperalgesia was also examined in
mice in which SOD levels were manipulated pharmacologically
or genetically. Our results show that the spinal SOD-2 activity
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levels correlate with levels of capsaicin-induced secondary hyper-
algesia. Moreover, elevated mitochondrial superoxide accumula-
tion after capsaicin treatment is, in part, attributable to inactiva-
tion of SOD-2 proteins. Thus, these data suggest that endogenous
levels of mitochondrial SOD-2 determine the levels of spinal su-
peroxide, which in turn determine the levels of central sensitiza-
tion and, thus, capsaicin-induced secondary hyperalgesia.
Materials and Methods
Experimental animals
Young adult male mice (20 –25 g of body weight) of various stains were
used for this study. Wild-type FVB/NJ mice and heterozygous SOD-2
knock-out (KO) mice [B6.129S7-Sod2 tm1Leb/J] in the C57BL/6 back-
ground were purchased from Jackson Laboratory, and heterozygous
SOD-2 transgenic mice (TG) in the C57BL/6 background originated
from Ho et al. (1998). All heterozygous mice (SOD-2 KO and SOD-2 TG)
were compared with wild-type littermates for all experiments. Animals
were housed in groups of four to five in plastic cages with soft bedding
and ad libitum access to food and water under a 12 h light/dark cycle. All
animals were acclimated for 1 week before any experimental procedures.
All experimental protocols were approved by the Animal Care and Use
Committee at the University of Texas Medical Branch and are in accor-
dance with the National Institutes of Health’s Guide for the Care and Use
of Laboratory Animals.
Capsaicin injection
For injection of capsaicin, each mouse was anesthetized with isoflurane
(2.0% for induction and 1.5% for maintenance) in a flow of O2 and
placed in a prone position. Capsaicin solution (0.5%) was made by dis-
solving 5 mg of capsaicin (Sigma) in 1 ml of vehicle containing 20%
alcohol and 7% Tween 80 in saline, immediately before injection. For
behavioral testing, 5 l of capsaicin solution was injected intradermally
using a 30 gauge needle attached to a Hamilton syringe. The needle was
inserted near the heel of the left hind foot and advanced to the middle of
the plantar surface as shown in Figure 1a. A successful injection was
noted by the formation of a “bleb” 2 mm in diameter. The insertion site
was pressed for 1 min to prevent leakage of the solution after removal of
the needle. Anesthesia was discontinued and the mice were aroused
within 5 min and then returned to their cages. For SOD protein and
activity analysis and ROS imaging, 25 l of 0.5% capsaicin was injected
into multiple sites of both the plantar and dorsal surface of the left hind
foot to increase receptive fields of capsaicin responsive afferents and,
thus, to maximize the number of affected neurons in the spinal cord.
Behavioral testing for assessment of mechanical sensitivity of
the foot
Foot withdrawal frequencies in response to von Frey stimuli were mea-
sured and used as an indicator of mechanical sensitivity. Tests were con-
ducted blindly and foot withdrawal responses were assessed before and 1,
2, 3, 5, 8, 24 and 48 h (sometimes 72 h) after intradermal capsaicin
injection. For each test, the animal was placed in a plastic chamber on top
of a mesh screen platform and was habituated for at least 10 min. Me-
chanical stimuli were applied from underneath to the plantar surface of
the left hind foot. The mechanical sensitivity of the foot was determined
by the frequency of positive foot withdrawal responses to 10 repetitive
von Frey stimuli. The von Frey monofilaments of 2.48, 3.00, or 3.61
(vF#2.48, #3.0, or #3.61), which are equivalent to 0.03, 0.10, or 0.41 g
force, respectively, were used for stimulation. For mechanical stimula-
tion, a von Frey filament was applied perpendicular to the stimulation
site with sufficient force to bend the filament for 2–3 s and then removed.
An abrupt withdrawal with or without licking of the foot, during stimu-
lation, or immediately after stimulus removal, was considered a positive
response. Each test was composed of 10 stimuli for each area. The num-
ber of positive responses was converted into a percentage with 10 positive
responses corresponding to 100%. Primary and secondary hyperalgesia
were assessed as shown previously (Schwartz et al., 2008). In brief, pri-
mary hyperalgesia was assessed by applying von Frey filaments to site P in
Figure 1a, which is 2 mm distal from the injection site (site I). For sec-
ondary hyperalgesia, a von Frey monofilament was applied at the base
and/or proximal part of the third and fourth toes (site S). This area is at a
sufficient distance from the capsaicin injection site (7 mm), and is thus
not directly affected by capsaicin, but becomes extremely sensitive and
thus is identified as a site of secondary hyperalgesia.
Direct transcutaneous intrathecal injection
For direct transcutaneous intrathecal injection, a modified method (Lee
et al., 2007) of the original intrathecal injection method (Hylden and
Wilcox, 1980) was used. Mice were anesthetized (2.0% for induction and
1.5% for maintenance) with isoflurane in a flow of O2, placed in a prone
position, and the hair on their back was clipped. The caudal paralumbar
region, just cranial to the iliac crests, was securely held by the thumb and
middle fingers of the left hand, and the index finger was placed on the tip
of sixth lumbar (L6) spinous process, the highest point of the vertebral
column. A 1.5-inch-long 30 gauge needle connected to a Hamilton sy-
ringe was positioned underneath the index finger with the beveled side
facing upward in a forward direction. The needle was inserted into the
tissue at a 45° angle. The angle of the needle was maintained until the
needle went through the fifth intervertebral space (L5–L6) and “slipped
in” causing a sudden lateral movement of the tail. Solution was injected
at a rate of 1 l/s. The needle was held in position for 10 s and removed
slowly to avoid any outflow of the solution. Anesthesia was discontinued
and the mice were aroused within 5 min and then returned to their cages.
Administration of drugs
SOD mimetic, Mn (III) tetrakis(4-benzoic acid) porphyrin. Mn (III)
tetrakis(4-benzoic acid) porphyrin (MnTBAP; 5mg; Calbiochem) was
dissolved in 2.5 ml of saline, and 100 l of this solution was injected
intraperitoneally per 20 g of body weight (10 mg/kg). The same volume
of saline was used as a control. To determine the role of SOD in capsaicin-
induced hyperalgesia, MnTBAP was administered either 0.5 h before
(pretreatment) or 1.5 h after (posttreatment) capsaicin treatment. To
examine the dose–response, one of three doses of MnTBAP, 2 mg, 5 mg,
or 10 mg/kg of body weight, or saline was injected intraperitoneally, 1.5 h
(posttreatment) after intradermal injection of capsaicin.
SOD inhibitor, diethylthiocarbamate. Diethylthiocarbamate (DETC;
0.2 mg; Sigma) was dissolved in 4 ml of saline, and 5 l of this solution
was injected intrathecally (0.05 mg). The same volume of saline was used
as a control. To determine the role of SOD in capsaicin-induced hyper-
algesia, DETC was administered either 0.5 h before capsaicin treatment
(pretreatment) or 1.5 h after (posttreatment). To examine the dose–
response, one of three doses of DETC, 0.01, 0.02, or 0.05 mg, or saline was
injected intrathecally, 1.5 h (posttreatment) after intradermal injection
of capsaicin.
ROS scavengers: phenyl N-tert-butylnitrone; 4-hydroxy-2,2,6,6-
tetramethylpiperidine 1-oxyl. Either 0.2 mg of phenyl N-tert-butylnitrone
(PBN) or 0.5 mg of 4-hydroxy-2,2,6,6-tetramethylpiperidine 1-oxyl
(TEMPOL; Sigma) was dissolved in 1 ml of saline, and 5 l was injected
intrathecally 15 min after capsaicin injection (200 g of PBN; 500 g of
TEMPOL). The same volume of saline was used as a control.
Western blot analysis of SOD-2
At the time of tissue sampling, mice were anesthetized deeply with so-
dium pentobarbital (Nembutal, 75 mg/kg) and perfused through the
aorta with cold saline for 1 min. The L4 –5 spinal cord segments were
removed after laminectomy and divided into right (contralateral) and
left (ipsilateral to capsaicin injection) halves and frozen immediately on
dry ice. The spinal cord segments were homogenized, using a bead beater,
in 100 l of lysis buffer (20 mM Tris-Base, 150 mM NaCL, 10% glycerol,
0.1% Triton X-100, 1% Chaps, 2 mM EGTA, 1% protease inhibitor mix-
ture). Lysates were centrifuged at 12,500  g for 30 min at 4°C. The
supernatants were collected and protein concentration was determined
using the bicinchoninic acid protein assay (BCA; Pierce). Protein (40 g)
was resuspended in 40 l of Laemmli sample buffer and 5%
2-mercaptoethanol and heated for 10 min. The samples were loaded in
15% SDS polyacrylamide gels. After separation by SDS-PAGE, proteins
were transferred electrophoretically to polyvinylidene fluoride (PVDF)
membranes and blocked. For detection of SOD-2, blots were incubated
with rabbit polyclonal anti-SOD-2 (1:3000 dilution; Upstate Cell Signal-
ing) and then incubated with anti-rabbit horseradish peroxidase-
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conjugated secondary antibody (1:3000 dilution; Bio-Rad). The specific
complex was detected by an enhanced chemiluminescence detection sys-
tem. The density levels of SOD-2 bands were quantified by using Meta-
Morph software (Molecular Devices). Equal protein loading was deter-
mined using -actin (1:10,000 dilution; Sigma) expression as a control.
Immunoprecipitation assay and Western blot analysis
of N-SOD-2
The L4 –5 spinal cord segments were sampled after cold saline perfusion
as described in the previous section. The spinal cord segment was ho-
mogenized, using a bead beater, in 100 l of lysis buffer. After homoge-
nization, solubilized extracts were sonicated and centrifuged at 12,500 
g. The supernatants were collected and stored at 80°C immediately.
Protein concentration was determined by BCA method, as described in
Western blot analysis of SOD-2. Solubilized proteins (40 g) were incu-
bated with agarose-conjugated anti-nitrotyrosine antibody (Upstate Cell
Signaling) overnight at 4°C. Agarose beads were collected by centrifuga-
tion at 12,500  g, washed in PBS, and collected. The mixture of the
beads-antibody and binding proteins complex was resuspended in 50 l
of Laemmli sample buffer (Bio-Rad) and 5% 2-mercaptoethanol (Bio-
Rad), and heated. The samples were loaded in 15% SDS-PAGE minigels.
After separation by SDS-PAGE, proteins were transferred electrophoreti-
cally to PVDF membranes (Bio-Rad), and Western blots were performed
as above. Mouse brain treated with peroxynitrite for 10 min (Upstate Cell
Signaling) was used as a positive control.
SOD-2 activity measurement and analysis
Tissue samples were homogenized in 50 mM sodium phosphate buffer,
ph 7.4. The homogenates were centrifuged for 20 min at 12,500  g;
supernatant was collected and stored on ice. Protein concentration was
determined by BCA method as above. SOD activity was measured using
a microtiter plate assay for SOD using a water soluble tetrazolium
(WST-1) salt (Peskin and Winterbourn, 2000). The reagent mixture for
detection consisted of the following: assay buffer: 1 mM
diethylenetriamine-pentaacetic acid (DTPA; Sigma), 1 mM hypoxan-
thine (Sigma), 50 mM phosphate buffer, pH 8.0; Catalase: 2 mg/ml (Sig-
ma); WST-1: 50 M (Dojindo Laboratories); and xanthine oxidase: 4.5
mU/ml (Sigma). Xanthine oxidase was added to the reaction mixture
immediately before starting the assay. Samples were diluted 1:10, and
each sample was pipetted in triplicates as well as standards. Reagent
mixture (200 l) per well was pipetted into each well and absorbance was
read at 450 nm from time 0 min and every 10 min for 1 h on a microplate
reader (model 680-UV, Bio-Rad). Bovine Cu/Zn SOD (Sigma) was used
as a standard and final SOD concentrations of 0, 1, 3, 10, 30, and 100
ng/well were used for the standard curve. SOD1 activity was inhibited, by
performing the assay in the presence of 2 mM NaCN 30 min before assay.
In vivo ROS imaging: mitochondrial superoxide using MitoSox
MitoSox Red (Invitrogen) was dissolved in a 1:1 mixture of dimethylsulf-
oxide (DMSO) and saline to a final concentration of 33 M. Under isoflu-
rane anesthesia, 10 l of MitoSox was injected intrathecally by using a
direct transcutaneous intrathecal injection method described previously.
Approximately 23 h after MitoSox injection, mice received an intrader-
mal injection of either capsaicin (0.5%, 25 l) or the same volume of
vehicle on both the plantar and dorsal surfaces of the left hind foot. Mice
remained under 1.5% isoflurane anesthesia for 30 min to suppress any
side effects induced by capsaicin. Mice were perfused through the aorta
with saline followed by fixative containing 4% paraformaldehyde 1 h
after capsaicin injection, and the L4 –L5 spinal cord segments were re-
moved. The cord was postfixed 4 –15 h in the perfusion fixative, equili-
brated in 30% sucrose, cryosectioned at 30 m, and mounted on gelatin
coated slides. The sections were examined under a fluorescent micro-
scope with a rhodamine filter. Two different regions of the dorsal horn
were photographed from 10 randomly selected sections from each ani-
mal: the lateral part of laminas I-II and laminas III-V. Photographs were
taken with a Q-Imaging Retiga 2000R digital camera attached to an
Olympus BX50 microscope using a 63 oil objective lens and saved as
digital image files. The number of MitoSox-positive cellular profiles with
distinctive nuclei (dark oval shaped space surrounded by red granules)
was counted from these pictures.
ROS producing spinothalamic tract neurons: MitoSox and
fluorogold double labeling
To identify spinothalamic tract (STT) neurons, a retrograde marker flu-
orogold (FG; Fluorochrome) was injected into the ventroposterior lat-
eral thalamic nucleus (VPL). For FG injection, mice were anesthetized
with sodium pentobarbital (75 mg/kg, i.p.) and placed in a stereotactic
frame (Stoelting Company). A burr hole was made on the cranium at 1.5
mm posterior to the bregma and 1.62 mm lateral from the midline. A
Hamilton syringe was inserted to 3.6 mm depth from the brain surface
and 1 l of FG (4% in d.w.) was injected into the VPL at a rate of 0.1
l/min. Twenty minutes later, the needle was removed, the wounds were
sutured, and the mice were returned to their cage after recovering from
anesthesia. Three to four days later, mice were treated with MitoSox and
capsaicin as described above and the spinal cord tissues were processed
and examined. The spinal cord sections were examined under a fluores-
cent microscope with rhodamine and DAPI filters. FG labeled STT neu-
rons were photographed for FG and MitoSox from 10 randomly selected
sections from each animal. The number of double labeled, FG and
MitoSox, STT neurons were counted in each animal and averaged in
capsaicin (n  5) and vehicle (n  5) groups.
Statistical analysis
Data are presented as mean  SEM and were analyzed using the statisti-
cal program SigmaStat (Version 3.1, Systat Software). Statistical analyses
for differences in changes over time in multiple groups were performed
using two-way ANOVA with one repeated factor (time), followed by
Duncan’s post hoc test. Differences of values in different groups were
tested using the Student’s t test (when comparing two groups) or the
one-way ANOVA (when comparing more than two groups) followed by
post hoc pairwise multiple comparisons. All statistical tests were evalu-
ated at an  level of significance of 0.05.
Results
Confirmation of primary and secondary hyperalgesia
After an intradermal injection of capsaicin in mice, primary and
secondary hyperalgesia were determined by applying a von Frey
monofilament to sites P and S in Figure 1a, respectively. It is well
known that after capsaicin injection only mechanical, but no
heat, secondary hyperalgesia develops; whereas, both mechanical
and heat components are present in primary hyperalgesia (Tore-
björk et al., 1992; Willis, 2001). Using this feature, we attempted
to confirm the sites testing for both primary and secondary hy-
peralgesia. Two hours after an intradermal capsaicin injection to
the foot, thermal hyperalgesia developed, as shown by 44.5 
7.31% decrease in foot withdrawal latency (n  6; p  0.05 by
paired Student’s t test) from baseline values, at the capsaicin in-
jection site (site P), but there was no statistical difference in heat
response at site S (85.1  6.72% from baseline value). However
when mechanical sensitivity was measured in the same mice, me-
chanical hyperalgesia developed at both sites P and S similar to
the results of all experiments in this study (Figs. 1–2). Therefore,
the data confirm that these two tested sites P and S elicit primary
and secondary hyperalgesia, respectively.
Superoxide is involved in capsaicin-induced
secondary hyperalgesia
To test whether superoxide is involved in capsaicin-induced hy-
peralgesia, the effect of a SOD mimetic, MnTBAP, and a SOD
inhibitor, DETC, was examined on pain. Systemic (intraperito-
neal) MnTBAP (10 mg/kg) treatment, 1.5 h after capsaicin injec-
tion, had no effect on the primary hyperalgesia (Fig. 1b). The
same treatment, however, showed a significant reduction on the
secondary hyperalgesia (Fig. 1c), which lasted 6 h. In a dose–
response study, both 5 and 10 mg/kg of MnTBAP produced
graded antihyperalgesic effect, whereas, 2 mg/kg had no effect
compared with the saline-treated group. The fact that a SOD
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mimetic produced antihyperalgesia only
on secondary hyperalgesia suggests that
superoxide is involved in central
sensitization.
Intrathecal injection of SOD inhibitor
DETC (0.05 mg) 1.5 h after capsaicin
treatment, in contrast, significantly en-
hanced and prolonged the secondary hy-
peralgesia but not the primary hyperalge-
sia (Fig. 2a,b). The enhanced hyperalgesia
lasted up to 24 h with the highest dose
tested (0.05 mg) but for 8 h with two lower
doses (0.02 and 0.01 mg). In a dose–
response study, all three doses showed
graded enhanced hyperalgesia compared
with the saline-treated group. Because
DETC would block SOD activity and lead
to superoxide accumulation, the enhance-
ment of capsaicin-induced secondary hy-
peralgesia by DETC also supports the idea
of superoxide involvement in central
sensitization.
Although posttreatment of either
MnTBAP or DETC suggests that superox-
ide is involved in the maintenance of sec-
ondary hyperalgesia, it is not known
whether superoxide is also critical for the
development of capsaicin-induced hyper-
algesia. To address this issue, mice were
treated with either MnTBAP or DETC
0.5 h before capsaicin treatment and me-
chanical hyperalgesia was measured. Pre-
treatment with MnTBAP (10 mg/kg) sig-
nificantly reduced the capsaicin-induced
secondary hyperalgesia (Fig. 1e), whereas
DETC (0.05 mg) increased both the dura-
tion and the magnitude of capsaicin-
induced secondary hyperalgesia (Fig. 2d).
Neither MnTBAP nor DETC had any ef-
fect on the development of capsaicin-
induced primary hyperalgesia (Figs. 1d,
2c). These results suggest that superoxide
is critical for not only the development but
also the maintenance of capsaicin-induced
secondary hyperalgesia, thus suggesting a
role of superoxide in central sensitization.
Spinal levels of SOD-2 proteins were
unchanged but activities were decreased
after capsaicin treatment
Previous findings have indicated that the lev-
els of superoxide in the spinal cord are in-
creased in response to intradermal capsaicin.
We considered two possibilities that could
explain the spinal superoxide elevation: a de-
crease in SOD-2 protein levels and/or a decrease in SOD-2 activity
levels independent of a change in SOD-2 protein levels. First, the
total amount of SOD-2 protein in the spinal cord was measured by
Western blotting. As shown in Figure 3a, the levels of SOD-2 protein
in the ipsilateral L4–5 spinal cord did not change significantly 1 h
after capsaicin treatment compared with vehicle-treated mice. Thus,
the data indicate that changes in the total SOD protein levels are not
likely the cause of superoxide elevation.
In the next experiment, levels of SOD-2 activity in the spinal
cord were examined with a microtiter plate assay for SOD using a
WST-1 salt (Peskin and Winterbourn, 2000). SOD-2 activity lev-
els in the spinal cord after various manipulations in mice are
shown in Figure 3c. One hour after intradermal capsaicin treat-
ment (CAP-1 h), SOD-2 activity levels in the ipsilateral L4/5 spi-
nal cord were greatly decreased compared with that of vehicle-
treated mice. This decrease, however, was completely reversed
Figure 1. Effect of a SOD mimetic, MnTBAP, on capsaicin-induced hyperalgesia in response to vF (#3.61). a, Sites of capsaicin
injection and behavioral testing in the mouse hind foot. For capsaicin injection, a 30-gauge needle was inserted at the heel of the
foot (X) and advanced to the injection site (I), and capsaicin (25 g in 5 l of vehicle) was injected intradermally. Foot withdrawal
frequencies in response to von Frey stimuli were measured at site P for primary hyperalgesia and at site S for secondary hyperal-
gesia. b, c, Posttreatment effect; d, e, pretreatment effect. b– e,The mean  SEM (n  6/group) of primary (b, d) and secondary
hyperalgesia (c, e) are plotted against the postcapsaicin treatment time. MnTBAP [or vehicle saline (Sal)] was injected systemically
(intraperitoneally) 1.5 h after or 0.5 h before (indicated by downward arrows) capsaicin injection (indicated by upward arrow-
heads) for posttreatments or pretreatments, respectively. MnTBAP reduced capsaicin-induced secondary hyperalgesia in a dose-
dependent manner but not primary hyperalgesia. *Values significantly different from corresponding values of the vehicle-treated
group at p  0.05, by Duncan’s post hoc test after two-way repeated ANOVA. The data indicate that removal of superoxides
exogenously supplemented by a SOD mimetic, reduces capsaicin induced secondary hyperalgesia. MnTBAP(Mn-T) doses: 2, 5, or
10 mg/kg body weight.
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when the mice were treated with ROS scavengers, PBN or TEM-
POL, 15 min after capsaicin (CAPPBN-1 h and
CAPTEMPOL-1 h). When spinal SOD-2 activity levels were
measured 5 h after capsaicin treatment, the time mechanical hy-
peralgesia was significantly recovered from the peak response at
2 h after capsaicin treatment, SOD-2 activity levels also were
significantly recovered from the lowest value at 1 h after treat-
ment. The results show that spinal levels of SOD-2 activity, but
not SOD-2 protein levels, were decreased after intradermal cap-
saicin and then recovered by ROS scavenger treatment, suggest-
ing that ROS are involved in the reduction of SOD-2 activity. The
data also indicate that the levels of SOD-2 activity are correlated
with the amount of mechanical hypersensitivity. These findings
suggest that decreased SOD-2 activity in the spinal cord, at least
in part, results in elevation of superoxide and subsequently
hyperalgesia.
Nitrated SOD-2 levels were increased in the spinal cord after
capsaicin treatment
Because spinal SOD-2 activity levels were decreased without
changes in protein levels, we speculated that the SOD-2 enzyme
might have been inactivated. Inactivation of SOD can be caused
via nitration by peroxinitrite under some oxidative stress condi-
tions (Yamakura et al., 1998; Hylden and Wilcox, 1980;
Salvemini et al., 2001; Wang et al., 2004; Muscoli et al., 2004).
Therefore, the levels of nitrated SOD-2 (N-SOD-2) were mea-
sured in the L4/5 spinal cord of mice after
various manipulations. The results of
N-SOD-2 protein levels in the spinal cord
are shown in Figure 3b. The levels of
N-SOD-2 in the ipsilateral L4/5 spinal
cord were significantly increased (3-
fold) 1 h after capsaicin treatment (CAP-1
h), compared with that of vehicle-treated
mice. Five hours after capsaicin treatment
(CAP-5 h), spinal N-SOD-2 levels were
significantly reduced from the peak levels
but still slightly higher than, but not signif-
icantly different from, the vehicle-treated
mice (VEH-5 h). In addition, PBN and
TEMPOL treatment in combination with
capsaicin (CAPPBN-1 h and
CAPTEMPOL-1 h) did not alter the spi-
nal N-SOD-2 protein levels compared
with that of vehicle-treated mice (VEH-1
h). These results suggest that the decrease
in SOD-2 activity in the spinal cord after
capsaicin treatment is caused by inactiva-
tion of SOD-2 by nitration. The significant
reduction of N-SOD-2 levels by ROS scav-
engers also support the notion that ele-
vated levels of ROS are involved in nitra-
tion of SOD-2.
Capsaicin-induced hyperalgesia is
correlated to endogenous SOD-2
activity levels
Previous findings indicate that spinal SOD
activity levels are inversely correlated with
the levels of the capsaicin-induced second-
ary hyperalgesia. Because mitochondria is
speculated as the primary source of neuro-
nal ROS and SOD-2 is a mitochondria-
specific antioxidant, we determined whether SOD-2 could mod-
ulate hyperalgesia by measuring capsaicin-induced hyperalgesia
in mice whose SOD-2 expression was modified genetically. Two
genetically altered lines of mice were used: heterozygous SOD-2
overexpressing transgenic mice (SOD-2 TG) and heterozygous
SOD-2 underexpressing knock-out (SOD-2 KO) mice.
Capsaicin-induced mechanical hyperalgesia was determined as
described previously by measuring foot withdrawal frequencies
in response to vF filament stimuli. Mechanical sensitivity was
measured before and various times after a capsaicin treatment,
and results are shown in Figures 4 and 5.
In SOD-2 KO mice, capsaicin injection produced significantly
enhanced and prolonged (up to 48 h) secondary hyperalgesia
compared with wild-type littermates (Fig. 4b). Primary hyperal-
gesia also was increased modestly (Fig. 4a). When SOD-2 KO
mice were treated with TEMPOL, 1.5 h after capsaicin treatment,
secondary hyperalgesia quickly subsided 30 min after TEMPOL
treatment, returning to normal levels within 5 h after capsaicin
treatment (Fig. 4d). These results suggest that reduced levels of
SOD-2 in SOD-2 KO mice allowed increased superoxide accu-
mulation and enhanced secondary hyperalgesia. To confirm
whether the enhanced hyperalgesia is caused by reduced SOD-2
function in these mice, the levels of SOD-2 activity in the spinal
cord were also measured after capsaicin treatment in SOD-2 KO
mice. As shown in Figure 6, the basal endogenous levels of SOD-2
activity were significantly lower in SOD-2 KO mice (SOD-2 KO
Figure 2. Effect of a SOD inhibitor, DETC, on capsaicin-induced hyperalgesia in response to vF (#3.61). a, b, Posttreatment
results; c, d, pretreatment results. The mean  SEM (n  6/group) of primary (a, c) and secondary hyperalgesia (b, d) are plotted
against the postcapsaicin treatment time. DETC [or vehicle saline (Sal)] was injected intrathecally 1.5 h after or 0.5 h before
(indicated by downward arrows) capsaicin injection (indicated by upward arrowheads) for posttreatments or pretreatments,
respectively. DETC enhanced and prolonged capsaicin-induced secondary hyperalgesia in a dose-dependent manner but not
primary hyperalgesia. *Values significantly different from corresponding values of the vehicle-treated group at p  0.05, by
Duncan’s post hoc test after two-way repeated ANOVA. The data indicate that superoxide accumulation caused by inhibition of
SOD enhances and prolongs the capsaicin induced secondary hyperalgesia. DETC (D) doses: 0.01, 0.02, or 0.05 mg in 5 l of saline.
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VEH) compared with their wild-type littermates (Wt VEH). One
hour after capsaicin treatment, SOD-2 activity levels were further
decreased in SOD-2 KO mice (SOD-2 KO CAP) and, thus, sig-
nificantly lower than that of capsaicin-treated wild-type litter-
mates (Wt CAP) or of vehicle-treated SOD-2 KO mice (SOD-2
KO VEH).
In SOD-2 TG mice, the levels of capsaicin-induced primary
and secondary hyperalgesia were significantly reduced, especially
the secondary hyperalgesia, compared with that of wild-type lit-
termates (Fig. 5). Furthermore, the basal levels of SOD-2 activity
were approximately twice in SOD-2 TG mice (SOD-2 TG VEH)
compared with that of wild type (Wt VEH), and their levels did
not decrease significantly after capsaicin treatment (Fig. 6). These
results suggest that high levels of SOD-2 activity in SOD-2 TG
mice do not allow superoxide accumulation beyond normal lev-
els even after capsaicin treatment, and thus prevent the develop-
ment of secondary hyperalgesia. These results are consistent with
the notion that manipulating endogenous SOD-2 levels can ei-
ther enhance or reduce superoxide accumulation in the spinal
cord, which in turn will either increase or decrease central sensi-
tization, and thus influence the levels of hyperalgesia.
Mitochondrial superoxide accumulation in response to
capsaicin treatment is correlated to the levels of SOD-2
activity
Previous data indicate that superoxide accumulation in the spinal
cord is correlated to the levels of endogenous SOD-2 activity. To
determine whether mitochondrial superoxide levels in the spinal
dorsal horn were modified by SOD-2 activity levels, the number
of dorsal horn neurons showing increased superoxide was exam-
ined by using redox sensitive dye MitoSox. The reduced form of
colorless MitoSox was injected intrathecally 24 h before sacri-
ficing to allow dye to penetrate into the spinal cord and to seques-
ter in the mitochondria. One day later, mice were treated with
either capsaicin or vehicle and then killed by perfusion fixation
1 h after capsaicin treatment. This study was done in SOD-2 TG
and SOD-2 KO mice and their wild-type littermates with and
without capsaicin treatment, and the results were compared
among the different groups.
When the spinal cord sections were examined, oxidized
MitoSox labeling was detected as red fluorescent granules scat-
tered in the cytoplasm of cells (Fig. 7a), confirming our previous
findings (Schwartz et al., 2008). From a glance, it was clear that
the number of MitoSox-positive cells varied greatly among dif-
ferent tissues (Fig. 7a). Thus, quantification was done for the
number of MitoSox-positive cells in the superficial (laminas I-II)
and deep (laminas III-V) layers of the spinal dorsal horn. The
results of these studies are shown in Figure 7, b and c. In addition,
we also examined that the number of MitoSox-positive STT neu-
rons (Fig. 7d–f), representing ascending pain projection neurons.
MitoSox-positive STT neurons were increased significantly in
capsaicin-treated mice (76% of total STT neurons) compared
with that of vehicle-treated control group (52%).
Intradermal capsaicin (CAP) induced a significant increase in
the number of MitoSox-positive cells in the spinal dorsal horn
compared with that of vehicle treatment (VEH). In SOD-2 KO
mice, the number of MitoSox-positive cells is slightly higher, but
not significantly different, than wild-type mice with vehicle treat-
ment. However, the number of MitoSox-positive cells was in-
creased 2–3-fold after capsaicin treatment (SOD-2 KO CAP)
compared with that of vehicle treatment (SOD-2 KO VEH). This
increase in SOD-2 KO mice is significantly higher than that in
wild-type mice with capsaicin treatment. In SOD-2 TG mice,
there was no difference in the number of MitoSox-positive cells
after capsaicin treatment as well as basal levels compared with
that of vehicle-treated wild-type littermates. The results con-
firmed that the levels of endogenous SOD-2 determine the
amount of superoxide accumulated by the mitochondria, which
in turn induce central sensitization and secondary hyperalgesia.
Discussion
Our previous study has shown that increased levels of spinal ROS
are critical for the maintenance of capsaicin-induced secondary
hyperalgesia (Schwartz et al., 2008), suggesting ROS involvement
in central sensitization. The present study extends this work by
showing that mitochondrial superoxide is one of the major
sources of elevated spinal, but most likely not peripheral, ROS in
capsaicin-induced hyperalgesia, and inactivation of SOD-2 by
nitration contributes toward maintaining increased levels of mi-
Figure 3. Total SOD-2 protein, N-SOD-2 protein levels, and SOD-2 activity levels in the L4/5
spinal cord. a, Example of Western blot gel for SOD2 proteins. There is no change in the total
amount of SOD2 proteins in the spinal cord 1 h after capsaicin injection into the paw compared
with that of vehicle injection, and statistical analysis was done by nonpaired t test. b, Example
of Western blot gel for N-SOD2 proteins. One hour after intradermal capsaicin treatment (CAP-1
h), the inactivated N-SOD2 levels increase approximately three times compared with vehicle
treatment (VEH-1 h). Treatment with ROS scavengers (PBN: 100 mg/kg; TEMPOL: 300 mg/kg)
15 min after capsaicin injection (CAPPBN-1 h and CAPTEMPOL-1 h), completely reversed
N-SOD2 levels to normal levels. Five hours after capsaicin treatment (CAP-5 h), N-SOD2 levels
were slightly higher than vehicle-treated (VEH-5 h) control mice but not significantly different.
The data indicate that ROS accumulation in the spinal cord might be caused, in part, by inacti-
vation of SOD2 by nitration. c, The SOD2 activity levels were measured in six groups of mice (n 
12/group), and the average values (SEM) are shown in c. CAP-1 h and CAP-5 h: 1 and 5 h after
capsaicin; VEH-1 h and VEH-5 h: 1 and 5 h after vehicle; CAPPBN-1 h and CAPTEMPOL-1 h:
1 h after capsaicin plus PBN or TEMPOL treatment; PBN or TEMPOL was injected systemically
(intraperitoneally) 15 min after capsaicin. SOD activity levels were significantly reduced 1 h after
capsaicin, then moderately recovered at 5 h compared with that of vehicle treatment.
Capsaicin-induced reduction on SOD2 activity was completely recovered by treatment with a
ROS scavenger, PBN or TEMPOL. *Values significantly different from corresponding values in the
vehicle-treated group at p  0.05 (n  12), by Duncan’s post hoc test after one-way repeated
ANOVA. The data indicate that intradermal capsaicin induce the reduction in SOD2 activity in the
spinal cord resulting from ROS elevation.
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tochondrial superoxide. The fact that the level of capsaicin-
induced secondary hyperalgesia is correlated with the level of
SOD-2, further supports the idea that mitochondrial superoxide
controls the level of central sensitization. Increased and decreased
number of MitoSox-positive dorsal horn neurons, correlated
with changes in capsaicin-induced hyperalgesia in SOD-2 KO
and SOD-2 TG mice, is consistent with the
hypothesis that decreased mitochondrial
SOD-2 activity level significantly contrib-
utes to spinal superoxide increase and thus
hyperalgesia.
Importance of SOD-2 and superoxide
in a rat inflammatory pain model has been
proposed by others (Muscoli et al., 2004;
Wang et al., 2004), who suggested that
SOD-2 in the spinal cord and superoxides
in both the spinal cord and the peripheral
tissue are important in the carrageenan-
induced inflammatory thermal hyperalge-
sia in the rat. The present study extends
this earlier proposal by showing that (1)
spinal SOD-2 are important in capsaicin-
induced hyperalgesia in mice; (2) determi-
nation of hyperalgesia by the levels of en-
dogenous SOD-2 is clearly demonstrated
in mice in which SOD-2 levels are manip-
ulated genetically; (3) imaging data pro-
vide a direct evidence of decreased/in-
creased accumulation of spinal
superoxides because of increased/de-
creased levels of SOD-2 in relation to
capsaicin-induced hyperalgesia in mice;
and (4) the spinal cord seems to be the
major action site of superoxides and
SOD-2 in capsaicin-induced hyperalgesia,
suggesting the role of superoxides and
SOD-2 for the central sensitization
process.
To demonstrate that elevation of su-
peroxide levels in the spinal cord is a key
for the development and maintenance of
capsaicin-induced secondary hyperalge-
sia, we show that dismutation of superox-
ide by an exogenously supplied SOD mi-
metic, MnTBAP, reduces the secondary
hyperalgesia, but not the primary hyperal-
gesia, in capsaicin-treated mice. Thus,
the data suggest the main function of
MnTBAP is the reduction of central sensi-
tization by removing superoxide from the
spinal cord. In contrast, the capsaicin-
induced secondary hyperalgesia is signifi-
cantly enhanced by the SOD inhibitor
DETC. This result further supports the hy-
pothesis that SOD determines the levels of
superoxide in the spinal cord, which in
turn causes central sensitization and thus
secondary hyperalgesia. Thus, it is clear
that pain modulation by a SOD mimetic or
a SOD inhibitor is mainly achieved
through the reduction or increase of su-
peroxide in the spinal cord, respectively, in
capsaicin-induced hyperalgesia. However,
the possibility of ROS-induced sensitization of supraspinal re-
gions, which in turn influence spinal sensitization, cannot be
excluded because an intracerebroventricular injection of ROS
scavengers produces a small but significant antihyperalgesic ef-
fect in capsaicin-induced secondary hyperalgesia (Lee et al.,
2007).
Figure 4. a– d, Capsaicin-induced primary (a) and secondary (b) hyperalgesia in SOD-2 KO mice and ROS scavenger effect on
primary (c) and secondary (d) hyperalgesia. The average foot withdrawal frequencies (SEM, n  10 per group) in response to
vF (#3.61) stimuli are plotted against the postcapsaicin treatment (indicated by upward arrowheads) time. The capsaicin-induced
hyperalgesia, both primary and secondary, was significantly enhanced and prolonged in SOD-2 KO mice compared with that of
wild-type littermates. Posttreatment with a ROS scavenger, TEMPOL [500 g in 5 l of saline (Sal); indicated by downward
arrow], 1.5 h after capsaicin, significantly reduced secondary hyperalgesia but not primary hyperalgesia. Asterisks (*), Values are
significantly different from corresponding values in the control groups (wild-type mice in a, b; saline group in c, d) at p  0.05 by
Duncan’s post hoc test after two-way repeated ANOVA.
Figure 5. a, b, Capsaicin-induced primary (a) and secondary (b) hyperalgesia in SOD-2 TG mice in response to vF (#3.61). The
capsaicin-induced hyperalgesia, both primary and secondary, were significantly reduced in SOD-2 TG mice compared with wild-
type littermates. The effect is severer for secondary hyperalgesia than primary hyperalgesia; thus, secondary hyperalgesia is
almost nonexistent. Asterisks (*), Values are significantly different from corresponding values in the wild-type littermates (Wt
CAP) at p  0.05 (n  10) by Duncan’s post hoc test after two-way repeated ANOVA.
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Whereas the present study suggests that the spinal cord ap-
pears to be the main site of action of a SOD mimetic in capsaicin-
induced hyperalgesia, another study has shown that the SOD
mimetic, M40403, reduces carrageenan-induced inflammation
and hyperalgesia through both peripheral and central mecha-
nisms (Wang et al., 2004). We are not clear why these two studies
show different results. One reason for the difference in models
could be that the peripheral inflammatory factor is relatively
strong as in carrageen-induced hyperalgesia (Wang et al., 2004),
whereas it is small in acute capsaicin-induced hyperalgesia as
shown in this study.
Another important point related to the MnTBAP and DETC
study is that both drugs are nonspecific in terms of their subcel-
lular action sites; thus, they will change superoxide levels not only
in the mitochondria but also in the cytoplasm and extracellular
space. This issue was further probed in this study by using genet-
ically manipulated SOD-2 KO and SOD-2 TG mice to explore the
role of mitochondrial SOD. One other issue on the use of
MnTBAP is that it can also scavenge peroxynitrite (Hachmeister
et al., 2006) in addition to superoxide; thus, it is possible that the
reduction of secondary hyperalgesia by MnTBAP may be caused
by the removal of peroxinitrite. Future studies are warranted by
using more specific SOD mimetics when they become available.
The present study also shows that SOD-2 activity levels are
altered in the spinal cord after intradermal capsaicin injection
without reducing the total SOD-2 protein levels, thus suggesting
that inactivation of SOD-2 is important rather than changes in
protein levels. Nitration of SOD is one of the modes by which
SOD is inactivated (Yamakura et al., 1998; Macmillan-Crow and
Cruthirds, 2001; Echtay et al., 2002; Muscoli et al., 2004; Wang et
al., 2004; Demicheli et al., 2007). SOD nitration can be reversed
by removal of either superoxide or nitric oxide, inhibiting the
formation of peroxynitrite and peroxynitrite-mediated protein
nitration (Akizuki et al., 2000; Salvemini et al., 2001; Fries et al.,
2003). In line with this idea, a previous study has shown that
intraplantar injection of carrageenan induces thermal hyperalge-
sia (Salvemini et al., 1999; Wang et al., 2004) and increases nitra-
tion of spinal SOD-2 (Wang et al., 2004), and a SOD mimetic,
M40403, reverses these effects (Salvemini et al., 1999; Wang et al.,
2004). Increased spinal SOD-2 nitration is also found after intra-
thecal injection of NMDA, and this effect is reversed by a systemic
administration of a SOD mimetic (Muscoli et al. 2004). The
present study also confirms that both increased SOD-2 nitration
and decreased SOD-2 activity in the spinal cord coincide with the
capsaicin-induced secondary mechanical hyperalgesia. Thus, our
data are in agreement with previous studies in which SOD-2
nitration in the cord is critical for hyperalgesia. The reversal of
hyperalgesia and SOD-2 activity levels by a SOD mimetic is in
agreement with the known reversal process of nitrated SOD-2 by
removing superoxide from the spinal cord.
Previous studies (Muscoli et al. 2004; Wang et al. 2004) have
suggested that mitochondrial SOD, SOD-2, is critical for hyper-
algesia. This point is further illustrated by using genetically ma-
nipulated SOD-2 KO and SOD-2 TG mice in the present study. In
SOD-2 KO mice, the SOD-2 protein and activity levels are signif-
icantly lower and the magnitude of capsaicin-induced secondary
hyperalgesia is significantly greater compared with that of their
wild-type littermates. The effects are opposite in SOD-2 TG mice,
in which the level of SOD-2 activity is high in the spinal cord, and
the capsaicin-induced secondary hyperalgesia is almost nonexist-
ence. Thus, the data indicate that mitochondrial superoxide ac-
cumulation, resulting from the insufficiency of mitochondrial
antioxidant SOD-2, is critical for hyperalgesia. It is important to
note that in SOD-2 TG and SOD-2 KO mice, levels of primary
hyperalgesia were also modestly affected. This suggests that
SOD-2 manipulations change to some extent the physiological
properties of the primary afferents that contribute to primary
hyperalgesia. Furthermore, increased and decreased numbers of
MitoSox-positive dorsal horn neurons in response to intrader-
mal capsaicin in these SOD-2 KO and SOD-2 TG mice, respec-
tively, confirm that mitochondrial superoxide generation is the
major driver of ROS elevation in the spinal cord.
Although it is evident that elevated superoxide levels in the
mitochondria of dorsal horn neurons are critical for secondary
capsaicin-induced hyperalgesia, the exact mechanism of neuro-
nal sensitization by mitochondrial superoxide is not known. Pos-
sibilities include deregulation of membrane potentials because of
lipid peroxidation (Wang and Thayer, 2002; Choi et al., 2004) or
modification of cellular signal transduction pathways (Sluka et
al., 1997a; Palecek et al., 2002). Considering that hyperalgesia and
SOD-2 nitration is reversible within 30 min after treatment with
a SOD mimetic, it is likely that superoxide is involved in the
modification of reversible cellular signaling process rather than
permanent damage. It has been shown that central sensitization
involves activation of ligand-gated ion channels, the substance-P
receptor neurokinin-1 (NK1)-R (Sluka et al., 1997b; Palecek et
al., 2002), metabotropic glutamate receptors (mGLUR) (Ad-
wanikar et al., 2004; Park et al., 2006), and tyrosine kinase recep-
tors (trkB and Eph) (Ren and Dubner 2007). Furthermore, ROS
are considered to be small messenger molecules that modify cel-
lular signaling pathways (Kamata and Hirata 1999; Maher and
Schubert 2000). Thus, it is likely that an elevated level of ROS
leads the redox status of dorsal horn neurons toward oxidation
and, thus, changes the signal transduction pathways toward sen-
sitization. In addition, functional loss of glutamate transporters
and glutamine synthase (Trotti et al., 1996, 1999; Görg et al.,
2005) can lead to increased glutamate levels in the synaptic cleft
and overstimulation of the NMDA receptor. Thus, the functional
loss of transporters and enzymes in the presence of excess ROS
Figure 6. SOD2 activity levels in the L4/5 spinal cord in SOD-2 KO and SOD-2 TG mice with
and without intradermal capsaicin treatment. The endogenous SOD2 activity levels are signifi-
cantly lower in SOD-2 KO mice (SOD-2 KOVEH) and significantly higher in SOD-2 TG mice (SOD-2
TGVEH) compared with wild type (Wt-VEH). Capsaicin treatment (CAP-1 h), SOD2 activity levels
significantly decreased in Wt and SOD-2 KO mice but not in SOD-2 TG mice. *Values are signif-
icantly different between two linked groups at p  0.05 (n  12) by Bonferroni’s post hoc test
after one-way repeated ANOVA. ns, Nonsignificant.
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may also contribute toward central sensitization. Future studies
are thus warranted to explore detailed redox-sensitive signal
transduction pathways in the dorsal horn of the spinal cord.
In conclusion, our findings suggest that superoxide is partic-
ularly important in the sensory processing in the spinal cord in
capsaicin-induced secondary hyperalgesia. Our studies also sup-
port that SOD-2 nitration is a critical mechanism that maintains
elevated superoxide levels in the spinal cord after capsaicin treat-
ment. Finally, our findings suggest a therapeutic potential for the
manipulation of spinal SOD-2 activity in pain conditions.
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